LB Pharmaceuticals grants inducement options to new CMO and CFO
LB Pharmaceuticals granted inducement options to its new CMO and CFO for 200,000 shares at $37.22 each, vesting over four years under Nasdaq Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.